Oncolix, Inc.
company.status.inactiveCIK 1584137fmd_036Q0YY5G3359PV97KVQDCAGWRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2018, 20 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|
| Total revenues | – | 0 | – | – | – |
| Research and development | 0 | 0 | 0 | 1 | 0 |
| Selling, general and administrative | 0 | 0 | 0 | 1 | 1 |
| Total operating expenses | 0 | 0 | 0 | 1 | 2 |
| Operating income | – | – | (0) | (0) | – |
| Interest expense | (0) | (0) | 0 | 0 | – |
| Income before taxes | (0) | (0) | (0) | – | – |
| Net income | (0) | (0) | (0) | (1) | (3) |